Need Help?
14 March 2023
Cancers | Top 10 Cited Papers in 2022 in the Section “Cancer Biomarkers”
- “The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis”
by Deniz Can Guven, Taha Koray Sahin, Enes Erul, Saadettin Kilickap, Thilo Gambichler and Sercan Aksoy
Cancers 2022, 14(11), 2675; https://doi.org/10.3390/cancers14112675
Available online: https://www.mdpi.com/2072-6694/14/11/2675
- “Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy”
by Yuta Myojin, Takahiro Kodama, Ryotaro Sakamori, Kazuki Maesaka, Takayuki Matsumae, Yoshiyuki Sawai, Yasuharu Imai, Kazuyoshi Ohkawa, Masanori Miyazaki, Satoshi Tanaka et al.
Cancers 2022, 14(4), 883; https://doi.org/10.3390/cancers14040883
Available online: https://www.mdpi.com/2072-6694/14/4/883
- “HPRT1 Promotes Chemoresistance in Oral Squamous Cell Carcinoma via Activating MMP1/PI3K/Akt Signaling Pathway”
by Tong Wu, Zan Jiao, Yixuan Li, Xuan Su, Fan Yao, Jin Peng, Weichao Chen and Ankui Yang
Cancers 2022, 14(4), 855; https://doi.org/10.3390/cancers14040855
Available online: https://www.mdpi.com/2072-6694/14/4/855
- “Deciphering Tumour Heterogeneity: From Tissue to Liquid Biopsy”
by Pauline Gilson, Jean-Louis Merlin and Alexandre Harlé
Cancers 2022, 14(6), 1384; https://doi.org/10.3390/cancers14061384
Available online: https://www.mdpi.com/2072-6694/14/6/1384
- “Impact of HER2 Status on Pathological Response after Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer”
by Camille Domergue, Elodie Martin, Camille Lemarié, Pascal Jézéquel, Jean-Sebastien Frenel, Paule Augereau, Mario Campone and Anne Patsouris
Cancers 2022, 14(10), 2509; https://doi.org/10.3390/cancers14102509
Available online: https://www.mdpi.com/2072-6694/14/10/2509
- “Comprehensive Approach to Distinguish Patients with Solid Tumors from Healthy Controls by Combining Androgen Receptor Mutation p.H875Y with Cell-Free DNA Methylation and Circulating miRNAs”
by Elena Tomeva, Olivier J. Switzeny, Clemens Heitzinger, Berit Hippe and Alexander G. Haslberger
Cancers 2022, 14(2), 462; https://doi.org/10.3390/cancers14020462
Available online: https://www.mdpi.com/2072-6694/14/2/462
- “Contrast-Enhanced Ultrasound for Monitoring Treatment Response in Different Stages of Hepatocellular Carcinoma”
by Mariella Faccia, Matteo Garcovich, Maria Elena Ainora, Laura Riccardi, Maurizio Pompili, Antonio Gasbarrini and Maria Assunta Zocco
Cancers 2022, 14(3), 481; https://doi.org/10.3390/cancers14030481
Available online: https://www.mdpi.com/2072-6694/14/3/481
- “Long Noncoding RNA LINC02470 Sponges MicroRNA-143-3p and Enhances SMAD3-Mediated Epithelial-to-Mesenchymal Transition to Promote the Aggressive Properties of Bladder Cancer”
by Cheng-Shuo Huang, Chen-Hua Tsai, Cheng-Ping Yu, Ying-Si Wu, Ming-Fong Yee, Jar-Yi Ho and Dah-Shyong Yu
Cancers 2022, 14(4), 968; https://doi.org/10.3390/cancers14040968
Available online: https://www.mdpi.com/2072-6694/14/4/968
- “Imaging Kv1.3 Expressing Memory T Cells as a Marker of Immunotherapy Response”
by Julian L. Goggi, Shivashankar Khanapur, Boominathan Ramasamy, Siddesh V. Hartimath, Tang Jun Rong, Peter Cheng, Yun Xuan Tan, Xin Yi Yeo, Sangyong Jung, Stephanie Shee Min Goay et al.
Cancers 2022, 14(5), 1217; https://doi.org/10.3390/cancers14051217
Available online: https://www.mdpi.com/2072-6694/14/5/1217
- “Automatically Extracted Machine Learning Features from Preoperative CT to Early Predict Microvascular Invasion in HCC: The Role of the Zone of Transition (ZOT)”
by Matteo Renzulli, Margherita Mottola, Francesca Coppola, Maria Adriana Cocozza, Silvia Malavasi, Arrigo Cattabriga, Giulio Vara, Matteo Ravaioli, Matteo Cescon, Francesco Vasuri et al.
Cancers 2022, 14(7), 1816; https://doi.org/10.3390/cancers14071816
Available online: https://www.mdpi.com/2072-6694/14/7/1816
